TipRanks
Go Ultimate55% OFF

Sihuan Pharmaceutical Holdings Group (0460) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0460 Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Sihuan Pharmaceutical Holdings Group in the past 3 months

0460 Stock 12 Month Forecast

HKD 1.11▲(53.10% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Sihuan Pharmaceutical Holdings Group in the last 3 months. The average price target is HKD 1.11 with a high forecast of HKD 1.11 and a low forecast of HKD 1.11. The average price target represents a 53.10% change from the last price of HKD 0.73.
Highest Price TargetHKD 1.11Average Price TargetHKD 1.11Lowest Price TargetHKD 1.11

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:0460
Price TargetFollowArticle
GF Securities Analyst forecast on HK:0460Unknown AnalystNot RankedGF SecuritiesHKD 1.11buy53.10%UpsideReiterated09/23/26
Guotai Haitong Analyst forecast on HK:0460Unknown AnalystNot RankedGuotai HaitongHKD 1.50buy106.90%UpsideReiterated06/01/26
Citic Securities Analyst forecast on HK:0460Unknown AnalystNot RankedCitic SecuritiesHKD 2buy175.86%UpsideReiterated04/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

0460 Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0460
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy11111
Hold00000
Sell00000
Strong Sell00000
total11111

In the current month, 0460 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0460 average Analyst price target in the past 3 months is 1.11.

0460 Financial Forecast

HKD -2HKD -1.25HKD -0.5HKD 0.25HKD 1Q2 2025Q2 2026Q4 2026
ConsensusHKD 0.03

0460 Earnings Forecast

Next quarter’s earnings estimate for 0460 is HKD 0.03 with a range of ― to ―. The previous quarter’s EPS was HKD 0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

HKD 1BHKD 1.2BHKD 1.3BHKD 1.5BHKD 1.6BQ2 2025Q2 2026Q4 2026
ConsensusHKD 1.32B

0460 Sales Forecast

Next quarter’s sales forecast for 0460 is HKD 1.32B with a range of ― to ―. The previous quarter’s sales results were HKD 1.32B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0460 Stock Forecast FAQ

What is HK:0460’s average 12-month price target, according to analysts?
Based on analyst ratings, Sihuan Pharmaceutical Holdings Group’s 12-month average price target is HK$1.11.
What is HK:0460’s upside potential, based on the analysts’ average price target?
Sihuan Pharmaceutical Holdings Group has 53.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sihuan Pharmaceutical Holdings Group a Buy, Sell or Hold?
Sihuan Pharmaceutical Holdings Group has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sihuan Pharmaceutical Holdings Group’s share price target?
The average share price target for Sihuan Pharmaceutical Holdings Group is HK$1.11. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$1.11, and the lowest forecast is HK$1.11. The average share price target represents a 53.10% increase from the current price of HK$0.725.
What do analysts say about Sihuan Pharmaceutical Holdings Group?
Sihuan Pharmaceutical Holdings Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Sihuan Pharmaceutical Holdings Group?
To buy shares of HK:0460, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.